Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Klebsiella pneumoniae

ABSTRACT: Case study of recurrent urinary tract infection

PROVIDER: PRJNA589891 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	JAAEFG01.dat.gz	Other
	JAAEFG01.fasta.gz	Fasta.gz
	JAAEFG01.master.dat	Other
	JAAEFH01.dat.gz	Other

Items per page:

1 - 5 of 19

Similar Datasets

Klebsiella pneumoniae strain:USP-275675

Project description:Multidrug resistant bacteria from urinary tract infection of small animals

| PRJNA1062717 | ENA

Klebsiella pneumoniae

Project description:In vitro and in vivo assessments of two newly isolated bacteriophages against a ST13 urinary tract infection Klebsiella pneumoniae

| PRJNA821689 | ENA

DNA Copy Number Variations in Children with Vesicoureteral Reflux and Urinary Tract Infections

Project description:RIVUR Trial participants had Agilent 1M probe and or Nimblegen 2.1M probe aCGH performed on genomic DNA. The study was designed to discover DNA copy number variations in genes critical in kidney/urinary tract development and urinary tract infection susceptibility. Reference DNA used is a single male sample

2019-04-15 | E-MTAB-7890 | biostudies-arrayexpress

Human Urinary Proteome in Vesicoureteral Reflux

Project description:Vesicoureteral reflux (VUR) is a common pediatric condition that predisposes children to renal damage after urinary tract infection (UTI). We profiled the urinary proteome of VUR patients with recurrent UTI and renal scarring to identify potential biomarkers characterizing this condition. Urine was obtained from 22 age-matched controls and 22 patients with low grade VUR (1-3 out of 5), renal scarring, and history of recurrent UTI. Proteins extracted from these samples were analyzed by mass spectrometry for protein identification and quantitation for comparison.

2018-10-05 | PXD010469 | Pride

Project description:The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection

| PRJNA487122 | ENA

Escherichia coli IAI39

Project description:Urinary tract infection isolate

| PRJNA33411 | ENA

Escherichia coli UMN026

Project description:Urinary tract infection isolate

| PRJNA33415 | ENA

Klebsiella pneumoniae strain:IR27 | isolate:Urinary Tract Infection (UTI)

Project description:Klebsiella pneumoniae strain:IR27 | isolate:Urinary Tract Infection (UTI) Genome sequencing and assembly

| PRJNA681078 | ENA

Project description:Effect of Methenamine Hippurate on the Urinary Microbiome of Women with Recurrent Urinary Tract Infection

| PRJNA1067534 | ENA

Gene expression profile in patients inoculated with E. coli 83972

Project description:Urinary tract infections (UTIs) constitute a highly relevant model of microbial adaptation, in which the contrasting effects of pathogens and commensals on host tissues are clearly displayed. While virulent Escherichia coli cause severe, potentially life-threatening disease by breaking the inertia of the mucosal barrier and infecting the kidneys, the most common outcome of bacteriuria is an asymptomatic carrier state resembling commensalism at other mucosal sites. It remains unclear if the lack of destructive inflammation merely reflects low virulence or if carrier strains actively inhibit disease associated responses in the host. To address this question, we examined the effects of asymptomatic bacterial carriage on host gene expression. Therapeutic urinary tract inoculation with the prototype ABU strain E. coli 83972 is a safe alternative approach in patients with therapy-resistant recurrent UTI. The strain establishes persistent bacteriuria, protecting patients against super-infection with more virulent strains. Using this protocol, we examined if the establishment of asymptomatic bacterial carriage alters host gene expression. After antibiotic treatment to remove prior infection, patients were inoculated with E. coli 83972 through a catheter. Blood samples were obtained before and 24 h after inoculation.

2013-02-23 | E-GEOD-43838 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data